Please login to the form below
Tcelna
This page shows the latest Tcelna news and features for those working in and with pharma, biotech and healthcare.
Merck KGaA drops Ono-partnered multiple sclerosis drug
It also has a licensing deal in place for Tcelna (imilecleucel-T), a personalised treatment for secondary-progressive MS developed by Opexa Therapeutics that is in phase IIb testing with
Latest news
-
Currencies hit Merck Serono sales but firm says it is 'on course'
Overall groups sales down to €2.84bn for second quarter of 2013
-
Merck KGaA to meet 2014 financial targets one year early
and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.
-
Merck KGaA and Opexa enter MS deal
Merck KGaA and Opexa enter MS deal. Will develop personalised T-cell based medicine Tcelna. ... During the SPMS trial, patients undergo two annual courses of Tcelna treatment, consisting of five injections per year. “
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Pharma deals during February 2013
sales. In the other option deal, Merck Serono has acquired an option over Opexa Therapeutics' phase IIb Tcelna (imilecleucel-T) vaccine for MS (for all territories except Japan). ... Tcelna is being developed as a personalised therapy specifically
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and benefits
- Project Manager, Medical Communications, London
-
Excellent Salary
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Programme Executive
-
Salary TBC
Subscribe to our email news alerts
No results were found
- P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
- Publicis LifeBrands Team win UK young Cannes Lions competition
- Sobi poaches Pfizer’s Fredrick Wetterlundh
- Rigel and Ultragenyx claim approvals for rare drugs
- VCCP Health strengthens client service team
- Is agile working benefiting the employee or the organisation?
PMHub
McCann Complete Medical
Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
